FDA Import Refusal AEK-9601308-9/10002/1 — Eli Lilly Japan K.K.Seishin Laboratories
The FDA refused shipment AEK-9601308-9/10002/1 from Eli Lilly Japan K.K.Seishin Laboratories (Japan) on Jul 27, 2026. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 4 other import refusals on record.
Refusal Details
- Date
- Jul 27, 2026
- Country
- Japan
- Product Category
- Drugs and Biologics
- Product Code
- 61PDL74 TIRZEPATIDE (ANTI-DIABETIC)
- Charges
- 75